Standards Reference
![(2S)-2-[Butanoyl[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid (MM0487.04-0025)](https://www.lgcstandards.com/medias/sys_master/root/hbe/h38/9879111401502/Mikromol.svg)
![(2S)-2-[Butanoyl[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid (MM0487.04-0025)](https://assets.lgcstandards.com/sys-master%2Fimages%2Fh9c%2Fhab%2F10561447624734%2F3728.png)
(2S)-2-[Butanoyl[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid (MM0487.04-0025)
Sinônimos: Valsartan Imp. C (EP), Valsartan USP Related Compound B, Valsartan USP RC B, (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid, Valsartan Imp. C (EP), Valsartan Related Compound B (USP), Valsartan Related Compound B, Valsartan Impurity C
Descrição EP: Valsartan Impurity C
Código do Produto:
MM0487.04-0025
Número CAS:
952652-79-8
Product Categories:
Cardiac drugs and beta blockers Impurity Reference Materials Mikromol
API Family:
Valsartan
Product Types:
Impurity
Formato do Produto:
Neat
Fórmula Molecular:
Peso Molecular:
Choose quantity:
Quote Change Quantity Remove from QuoteNOTE: Click the "Quote" button to include this product in your quote.
NOTE: Click the "Change Quantity" button to change the quantity of this product in your quote.
NOTE: Click on the button "Remove from Quote" this product will be deleted from your quote.